Hiemke, C; Baumann, P
Pharmakokinetik, Pharmakogenetikund therapeutisches Drug MonitoringHolsboer F., Gründer, G., Benkert, O. (Hrsg). Handbuch der Psychopharmakotherapie. Heidelberg: Springer 2008
Stoffers, J; Lieb, K
Pharmakotherapie der Borderline-Persönlichkeitsstörung: Evidenzbasierte Empfehlungen für den klinischen Alltag.Info Neurologie & Psychiatrie. Bd. 10. H. 12. 2008 S. 30-35
Reed, NS; Mangioni, C; Malmstrom, H et al.
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).Eur J Cancer. Bd. 44. H. 6. 2008 S. 808-18
Stein, RA; Schröder, A
PhimoseM. Berger, W. Domschke, W. Hohenberger, T. Meinertz, K. Possinger, D. Reinhardt (Hrsg). Therapie-Handbuch. München: Urban & Fischer 2008
Garzia, L; D’Angelo, A; Amoresano, A et al.
Phosphorylation of nm23H1 by CKI induces complex formation with h-prune and promotes cell motilityOncogene. Bd. 27. H. 13. 2008 S. 1853-64
Weigl, JA; Puppe, W; Meyer, CU et al.
PID-ARI.net Infections and the Added Value of a Multilevel Research Network.Klin Padiatr. Bd. 220. H. 5. 2008 S. 281-6
Wilhelm, B; Pfützner, A; Fuchs, W et al.
Pioglitazon in Kombination mit Atvorvastatin verbessert die endotheliale Funktion und reduziert das kardiovaskuläre Risikoprofil.Diabetes und Stoffwechsel. Bd. 3. 2008 S. P 95
Thal, S; Heinemann, M; Pieter, D et al.
Pioglitazone and rosiglitazone reduce secondary brain damage after experimental brain traumaJ Neurosurg Anesth. Bd. 20. H. 4. 2008 S. 285-347
Schaefer, S; Vogt, T; Nowak, T et al.
Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy.J Neuroendocrinol. Bd. 20. H. 1. 2008 S. 104-9
Meikle, PJ; Whitfield, PD; Rozaklis, T et al.
Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic interventionBlood Cells Mol Dis. Bd. 40. H. 3. 2008 S. 420-7